These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9403430)

  • 21. A novel CCR5 mutation selectively affects immunoreactivity and fusogenic property of the HIV co-receptor.
    Zhao XY; Lee SS; Wong KH; Chan KC; He ZM; Ma S; Ng F; Chan CC; Ho T; Ng MH; Zheng BJ
    AIDS; 2004 Aug; 18(12):1729-32. PubMed ID: 15280786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Host genetic analysis of HIV type 1 subtype CRF01_AE (E)-infected Thai patients with different rates of disease progression.
    Louisirirotchanakul S; Sutthent R; Wasi C; Chuenchitra T; Nitayaphan S; Brown AE; Polonis VR; Nakayama EE; Shioda T; Liu H; Takebe Y
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1605-8. PubMed ID: 18160021
    [No Abstract]   [Full Text] [Related]  

  • 23. [Variant genotyping of CCR2-64I, SDF1-3' A and CCR5Delta32 in HIV-1 infected Chinese long-term nonprogressors].
    Wang SX; Shang H; Han XX; Zhang ZN; Wang YN; Zhang M; Jiang YJ; Liu J; Su YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):16-9. PubMed ID: 16642210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotypes and polymorphisms of mutant CCR5-delta 32, CCR2-64I and SDF1-3' a HIV-1 resistance alleles in indigenous Han Chinese.
    Wang F; Jin L; Lei Z; Shi H; Hong W; Xu D; Jiang J; Wang Y; Zhang B; Liu M; Li Y
    Chin Med J (Engl); 2001 Nov; 114(11):1162-6. PubMed ID: 11729511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression.
    de Roda Husman AM; van Rij RP; Blaak H; Broersen S; Schuitemaker H
    J Infect Dis; 1999 Oct; 180(4):1106-15. PubMed ID: 10479137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy.
    Lathey JL; Tierney C; Chang SY; D'Aquila RT; Bettendorf DM; Alexander HC; Santini CD; Hughes AM; Barroga CF; Spector SA; Landes JE; Hammer SM; Katzenstein DA
    J Infect Dis; 2001 Dec; 184(11):1402-11. PubMed ID: 11709782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCR2 polymorphism and HIV disease. Swiss HIV Cohort.
    Rizzardi GP; Morawetz RA; Vicenzi E; Ghezzi S; Poli G; Lazzarin A; Pantaleo G
    Nat Med; 1998 Mar; 4(3):252-3. PubMed ID: 9500580
    [No Abstract]   [Full Text] [Related]  

  • 28. Dominant effects of CCR2-CCR5 haplotypes in HIV-1 disease progression.
    Winkler CA; Hendel H; Carrington M; Smith MW; Nelson GW; O'brien SJ; Phair J; Vlahov D; Jacobson LP; Rappaport J; Vasilescu A; Bertin-Maghit S; An P; Lu W; Andrieu JM; Schächter F; Therwath A; Zagury JF
    J Acquir Immune Defic Syndr; 2004 Dec; 37(4):1534-8. PubMed ID: 15602133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variations in CC chemokine receptors and hypertension.
    Zhang M; Ardlie K; Wacholder S; Welch R; Chanock S; O'Brien TR
    Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of CCR5delta32, CCR2-64I and SDF1-3'A and plasma levels of SDF-1 in HIV-1 seronegative North Indians.
    Verma R; Gupta RB; Singh K; Bhasin R; Anand Shukla A; Chauhan SS; Luthra K
    J Clin Virol; 2007 Mar; 38(3):198-203. PubMed ID: 17240189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility to HIV infection--disentangling host genetics and host behavior.
    Telenti A; Ioannidis JP
    J Infect Dis; 2006 Jan; 193(1):4-6. PubMed ID: 16323124
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevalence of alleles associated with HIV resistance in Russia.
    Ryabov GS; Kazennova EV; Bobkova MR; Bobkov AF
    Genet Test; 2004; 8(1):73-6. PubMed ID: 15140377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of CCR5-{delta}32, CCR2-64I, and SDF1-3'A in Guangxi Zhuang population.
    Qijian Su ; Zhidan Mai ; Ning Zang ; Shuzhi Wu ; Xin Xiao ; Hao Liang
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(3):145-9. PubMed ID: 20530467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival with HIV infection: good luck or good breeding?
    Rowland-Jones SL
    Trends Genet; 1998 Sep; 14(9):343-5. PubMed ID: 9769726
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of polymorphisms of chemokine receptors on neurodevelopment and the onset of encephalopathy in children with perinatal HIV-1 infection.
    Llorente A; Brouwers P; Thompson B; Cheng I; Macmillan C; Larussa P; Mofenson L; Blasini I; Chase C
    Appl Neuropsychol; 2006; 13(3):180-9. PubMed ID: 17361671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of CCR5, CCR2 and SDF-1 gene polymorphisms in a population of HIV-1 infected individuals.
    Mazzucchelli R; Corvasce S; Violin M; Riva C; Bianchi R; Dehò L; Velleca R; Cibella J; Bada M; Moroni M; Galli M; Balotta C
    J Biol Regul Homeost Agents; 2001; 15(3):265-71. PubMed ID: 11693435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotypes of CCR2 and CCR5 chemokine receptors in human myasthenia gravis.
    Zhao X; Gharizadeh B; Hjelmström P; Pirskanen R; Nyrén P; Lefvert AK; Ghaderi M
    Int J Mol Med; 2003 Nov; 12(5):749-53. PubMed ID: 14533004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population.
    Salem AH; Farid E; Fadel R; Abu-Hijleh M; Almawi W; Han K; Batzer MA
    AIDS Res Hum Retroviruses; 2009 Oct; 25(10):973-7. PubMed ID: 19803715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCR2-64I polymorphism, syncytium-inducing human immunodeficiency virus strains, and disease progression.
    Vicenzi E; Ghezzi S; Brambilla A; Sheppard HW; Lazzarin A; Poli G; Michael NL
    J Infect Dis; 2000 Nov; 182(5):1579-80. PubMed ID: 11023492
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemokine genes--beating the odds.
    Stewart G
    Nat Med; 1998 Mar; 4(3):275-7. PubMed ID: 9500597
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.